Coevolution of COVID-19 research and China’s policies

Abstract

Background In the era of evidence-based policy-making (EBPM), scientific outputs and public policy should engage with each other in a more interactive and coherent way. Notably, this is becoming increasingly critical in preparing for public health emergencies. Methods To explore the coevolution dynamics between science and policy (SAP), this study explored the changes in, and development of, COVID-19 research in the early period of the COVID-19 outbreak in China, from 30 December 2019 to 26 June 2020. In this study, VOSviewer was adopted to calculate the link strength of items extracted from scientific publications, and machine learning clustering analysis of scientific publications was carried out to explore dynamic trends in scientific research. Trends in relevant policies that corresponded to changing trends in scientific research were then traced. Results The study observes a salient change in research content as follows: an earlier focus on “children and pregnant patients”, “common symptoms”, “nucleic acid test”, and “non-Chinese medicine” was gradually replaced with a focus on “aged patients”, “pregnant patients”, “severe symptoms and asymptomatic infection”, “antibody assay”, and “Chinese medicine”. “Mental health” is persistent throughout China’s COVID-19 research. Further, our research reveals a correlation between the evolution of COVID-19 policies and the dynamic development of COVID-19 research. The average issuance time of relevant COVID-19 policies in China is 8.36 days after the launching of related research. Conclusions In the early stage of the outbreak in China, the formulation of research-driven-COVID-19 policies and related scientific research followed a similar dynamic trend, which is clearly a manifestation of a coevolution model (CEM). The results of this study apply more broadly to the formulation of policies during public health emergencies, and provide the foundation for future EBPM research.

Influence on emergency digit replantation and outcome assessment after COVID-19 virus nucleic acid testing normalization

“…Typically, when facing public health emergency, results of scientific research pave the way for effective policy-addressing while policies become priority disciplines for management social behaviors (18). However, unlike other countries and regions globally, most policies in China are not established with reference sources, which increase the difficulties in daily administration (2). Thus, the dynamics between science and policy often requires postestablishment verification (19).…”

“…Prevention and control of corona virus disease 2019 (COVID-19) pandemic has attracted worldwide concern since 2020, and most countries and regions have established temporary social distancing policies during waves of the pneumonia outbreak (1). As one of the first batch of countries identifying COVID-19 pandemic, China has quickly controlled social transmission of the virus in the first wave of pandemic for the recovery of society and economy, thanks to the precise and strict policy implementation of Chinese public health system (2). Powerful molecular diagnostic methods have been explored to detect the infected, among which nucleic acid detection of severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) has gained an indispensable role due to its simplicity and fast report (3).…”

The Running Track of Government Responsibility During the Pandemic, Characteristic Analysis of Policy Documents Relevant to the COVID-19 Pandemic Released by Beijing Municipal Government in 2020

“…The COVID-19 pandemic caused huge social and economic losses. The rationale was that if the social and economic stability could not be maintained, it would, in turn, weaken the epidemic prevention and control and thus form a vicious circle (12)(13)(14). Therefore, both the economic and social stability and the policies for prevention and control of the epidemic were important for controlling the spread of the epidemic and safeguarding the people's health.…”

Regulating the product quality of COVID-19 antigen testing reagents: A tripartite evolutionary game analysis under China's legal framework

“…Academic research into the regulation of ADR product quality has significant implications for public health ( 22 ). To date, however, the academic community has failed to fully addressed the problem of low-quality ADRs and erroneous diagnostic results.…”